Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma
Clinical trial NCT00699296 · TERMINATED
Trial details
- NCT number
- NCT00699296
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2008-12-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.